| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $145.2M | -31.5% |
| Cost of Revenue | $11.4M | +50.8% |
| R&D Expense | $245.0M | +3166.5% |
| SG&A Expense | $265.5M | +20.6% |
| Operating Income | -$388.1M | -45.6% |
| Interest Expense | $11.3M | +0.0% |
| Pre-tax Income | -$376.1M | -35.2% |
| Income Tax | $223K | -28.8% |
| Net Income | -$111.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.2M | -5.7% |
| Accounts Receivable | $21.2M | +27.2% |
| Inventory | $9.4M | +35.9% |
| Current Assets | $616.8M | +26.8% |
| Total Assets | $788.9M | +17.3% |
| Current Liabilities | $177.9M | +25.1% |
| Total Liabilities | $588.1M | -6.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$280.0M | -50.3% |
| Capital Expenditures | $668K | +249.7% |
| Investing Cash Flow | $55.8M | +271.3% |
| Financing Cash Flow | $218.8M | +86.1% |
| Free Cash Flow | -$280.7M | -50.5% |
| +60.0% |
| EPS (Basic) | -$1.50 | +65.7% |
| EPS (Diluted) | -$1.50 | +65.7% |
| Stockholders' Equity |
| $200.8M |
| +368.6% |